Skip to main content

Want a detailed portfolio tracker?

Evolent Health (EVH) EBITDA (2014 - 2026)

Evolent Health (EVH) EBITDA from Jun 30, 2014 to Mar 31, 2026. The TTM Evolent Health (EVH) EBITDA is -$306M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual EBITDA

Quarterly EBITDA

Evolent Health (EVH) EBITDA CAGR table

PeriodCAGR
5 Years TTM+9.64%
10 Years TTM+3.95%
All Time TTM+36.77%

Annual EBITDA change of Evolent Health (EVH)

YearEBITDAChange
2026$11M-103.72%
2025-$294M-477.83%
2024$78M+49.21%
2023$52M-26.31%
2022$71M+301.82%
2021$18M-108.76%
2020-$201M-18.79%
2019-$248M+8277.36%
2018-$2.96M-92.69%
2017-$40M-81.62%
2016-$220M+514.88%
2015-$36MN/A
2014$0-100.00%
2013-$20MN/A

Comparison Evolent Health (EVH) five years EBITDA CAGR with competitors

Evolent Health (EVH) five years EBITDA CAGR is 9.64%.

TickerNamefive years EBITDA CAGRUpside
OPRXOptimizeRx Corp77.72%+706.45%
CCLDCareCloud Inc73.90%+666.76%
CCLDOCareCloud Inc73.90%+666.76%
SYSo-Young International Inc39.98%+314.81%
DOCSDoximity Inc - Class A32.10%+233.06%
HQYHealthequity Inc26.05%+170.33%
VEEVVeeva Systems Inc - Class A25.30%+162.49%
HCATHealth Catalyst Inc20.13%+108.91%
SDGRSchrodinger Inc18.03%+87.10%
PRVAPrivia Health Group Inc10.68%+10.77%
SOPHSOPHiA Genetics SA9.33%-3.21%
HSTMHealthstream Inc9.04%-6.22%
OMCLOmnicell Inc0.63%-93.48%
DRIODarioHealth Corp0.22%-97.73%